MedTrace Logo

Retrospective Evaluation of a Novel Biomimetic Synthetic Bone Substitute (Creos® Syntogain)

NCT06473545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2024-06-25

No results posted yet for this study

Summary

Guided bone regeneration (GBR) is a commonly performed technique, using autogenous grafts, allografts, xenografts, or synthetic bone grafts (SBG). Advantages of an "off the shelf" substitute, available anytime with limitless fabrication capacity that avoids human, or animal associated morbidity provides SBG with a very positive future perspective. This data collection is to retrospectively evaluate the long-term clinical performance of a CE marked biomimetic SBG substitute in patients with implant placement related bone regeneration treatments up to 72 months of follow-up. The study hypothesis states that a biomimetic SBG is a verified graft choice to be used clinically in patients with implant placement related bone regeneration treatments such as socket preservation with a delayed implant placement, GBR simultaneous with immediate implant placement, and sinus lift elevation with lateral approach.

Conditions

  • Tooth Loss
  • Partial-edentulism
  • Tooth Fracture
  • Edentulous Alveolar Ridge

Sponsors & Collaborators

  • Nobel Biocare

    collaborator INDUSTRY

  • International dentistry Research Group

    lead OTHER

Principal Investigators

  • Juan Mesquida, DDS · International Dentistry Research Group Clinical Director

  • Ignacio Ginebreda, DDS · International Dentistry Research Group co-Clinical Director

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-12-20
Completion
2023-12-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06473545 on ClinicalTrials.gov